9886 results about "Vinyl acetate" patented technology

Generally speaking, the present invention is a water-soluble copolymer film comprising a hydrolyzed copolymer of vinyl acetate and a second monomer, the resultant polyvinyl alcohol copolymer having a degree of hydrolysis, expressed as a percentage of vinyl acetate units converted to vinyl alcohol units, of from about 90% to 100%. The second monomer is preferably selected from the group of monomers having carboxylate functionality or sulfonate functionality. The resulting water-soluble copolymer film is disclosed for use in making pouches to contain a unit dose of liquid detergent, such as a liquid laundry detergent. However, it is an aspect of the copolymer film that film solubility is not significantly affected adversely by the detergent. Such film produces pouches having a greater storage shelf-life over prior art water-soluble film.

The invention provides a controlled release bioactive agent delivery device that includes a body member having a direction of extension, a longitudinal axis along the direction of extension, and a proximal end and a distal end, wherein at least a portion of the body member deviates from the direction of extension, and a polymeric coated composition in contact with the body member, the polymeric coated composition including a first polymer, a second polymer, and a bioactive agent, wherein the first polymer comprises polyalkyl(meth)acrylate, aromatic poly(meth)acrylate, or a combination of polyalkyl(meth)acrylate and aromatic poly(meth)acrylate, and wherein the second polymer comprises poly(ethylene-co-vinyl acetate). The invention also provides methods of delivering a bioactive agent to a patient in a controlled release manner, as well as methods of making a controlled release bioactive agent delivery device.

The invention relates to a transdermal analyte monitoring system comprising a medium adapted to interface with a biological membrane and to receive an analyte from the biological membrane and an electrode assembly comprising a plurality of electrodes, wherein the medium is adapted to react continuously with the analyte, an electrical signal is detected by the electrode assembly, and the electrical signal correlates to an analyte value. The analyte value may be the flux of the analyte through the biological membrane or the concentration of the analyte in a body fluid of a subject. The medium may comprise a vinyl acetate based hydrogel, an agarose based hydrogel, or a polyethylene glycol diacrylate (PEG-DA) based hydrogel, for example. The surface region of the electrode may comprise pure platinum. The system may include an interference filter located between the biological membrane and the electrode assembly for reducing interference in the system. The system may comprise a processor programmed to implement an error correction method that corrects for sensor drift.

A coating composition for use in coating implantable medical devices to improve their ability to release bioactive agents in vivo. The coating composition is particularly adapted for use with devices that undergo significant flexion and/or expansion in the course of their delivery and/or use, such as stents and catheters. The composition includes the bioactive agent in combination with a mixture of a first polymer component such as poly(butyl methacrylate) and a second polymer component such as poly(ethylene-co-vinyl acetate).

The invention relates to a composite comprising a weight fraction of single-wall carbon nanotubes and at least one polar polymer wherein the composite has an electrical and/or thermal conductivity enhanced over that of the polymer alone. The invention also comprises a method for making this polymer composition. The present application provides composite compositions that, over a wide range of single-wall carbon nanotube loading, have electrical conductivities exceeding those known in the art by more than one order of magnitude. The electrical conductivity enhancement depends on the weight fraction (F) of the single-wall carbon nanotubes in the composite. The electrical conductivity of the composite of this invention is at least 5 Siemens per centimeter (S/cm) at (F) of 0.5 (i.e. where single-wall carbon nanotube loading weight represents half of the total composite weight), at least 1 S/cm at a F of 0.1, at least 1×10^{−4 S/cm at (F) of 0.004, at least 6×10−9} S/cm at (F) of 0.001 and at least 3×10⁻¹⁶ S/cm (F) plus the intrinsic conductivity of the polymer matrix material at of 0.0001. The thermal conductivity enhancement is in excess of 1 Watt/m-° K. The polar polymer can be polycarbonate, poly(acrylic acid), poly(acrylic acid), poly(methacrylic acid), polyoxide, polysulfide, polysulfone, polyamides, polyester, polyurethane, polyimide, poly(vinyl acetate), poly(vinyl alcohol), poly(vinyl chloride), poly(vinyl pyridine), poly(vinyl pyrrolidone), copolymers thereof and combinations thereof. The composite can further comprise a nonpolar polymer, such as, a polyolefin polymer, polyethylene, polypropylene, polybutene, polyisobutene, polyisoprene, polystyrene, copolymers thereof and combinations thereof.

Disclosed is a catalyst. The catalyst comprises palladium, gold, and a support comprising titanium dioxide and tungsten trioxide. The support preferably comprises from 75 wt % to 99 wt % of titanium dioxide and from 1 wt % to 25 wt % of tungsten trioxide. A method for preparing the catalyst is also disclosed. The method comprises impregnating the support with a palladium compound and a gold compound, calcining the impregnated support, and then reducing the calcined support. Further disclosed is a method for preparing vinyl acetate with the catalyst. The catalyst exhibits improved catalytic activity and selectivity.

A catalyst for synthesizing vinyl acetate from acetylene and acetic acid is prepared from activated carbon, zinc acetate and alkaline bismuth carbonate in mass ratio of 100: (27-40): 0.026 by excessive solution dipping method.

The invention relates to a transdermal analyte monitoring system comprising a medium adapted to interface with a biological membrane and to receive an analyte from the biological membrane and an electrode assembly comprising a plurality of electrodes, wherein the medium is adapted to react continuously with the analyte, an electrical signal is detected by the electrode assembly, and the electrical signal correlates to an analyte value. The analyte value may be the flux of the analyte through the biological membrane or the concentration of the analyte in a body fluid of a subject. The medium may comprise a vinyl acetate based hydrogel, an agarose based hydrogel, or a polyethylene glycol diacrylate (PEG-DA) based hydrogel, for example. The surface region of the electrode may comprise pure platinum. The system may include an interference filter located between the biological membrane and the electrode assembly for reducing interference in the system. The system may comprise a processor programmed to implement an error correction method that corrects for sensor drift.

This invention provides an electrically conductive ink comprising an electrically conductive material and a vinyl chloride/vinyl acetate/hydroxyalkyl (meth)acrylate copolymer resin. There is also provided a noncontact-type medium comprising a base material and, provided on the base material, an electrically conductive circuit formed using the electrically conductive ink, and an IC chip mounted in the state of being electrically conducted to the electrically conductive circuit. An electrically conductive circuit, which is in a thin film form, can be used as an antenna circuit for noncontact-type media, has a low volume resistivity on the order of 10⁻⁵ Ω·cm, and is highly reliable under a high temperature and high humidity environment, can be formed by using the electrically conductive ink at a low temperature in a short time.

The present invention is directed to nanoparticulate compositions comprising a poorly soluble drug and at least one copolymer of vinyl pyrrolidone and vinyl acetate as a surface stabilizer adsorbed to the surface of the drug. Also encompassed by the invention are pharmaceutical compositions comprising a nanoparticulate composition of the invention, methods of making and using such nanoparticulate and pharmaceutical compositions.

The invention discloses a radiation pre-crosslinked ethylene-vinyl acetate (EVA) resin film which comprises the following components in parts by weight: 51-99.58 parts of EVA resin, 0.3-2 parts of organic peroxide crosslinking agent, 0.01-5 parts of assistant crosslinking agent, 0.1-2 parts of antioxidant, 0.01-2 parts of silane coupling agent, 0-40 parts of pigment and 0-40 parts of polyolefin elastomer. The invention also discloses a preparation method of the radiation pre-crosslinked EVA resin film, which comprises the steps of sufficiently mixing 51-99.58 parts of EVA resin, 0.3-2 parts of organic peroxide crosslinking agent, 0.01-5 parts of assistant crosslinking agent, 0.1-2 parts of antioxidant, 0.01-2 parts of silane coupling agent, 0-40 parts of pigment and 0-40 parts of polyolefin elastomer, and adding into an extruder; extruding and forming a film through a T-shaped flat mould; rolling and radiating to obtain the radiation pre-crosslinked EVA resin film. Since the film is partially crosslinked before use, the dimensional stability and heat resistance of the film are remarkably improved, thus the film is suitable for large-scale popularization and application.

The invention relates to an active carbon serving as a catalyst carrier and a treatment method and application thereof. After being subjected to heating and dipping treatment in hydrogen peroxide, the specific surface area of the active carbon is 900 to 1,300m<2>/g and the mesopore distribution ratio is 20 to 30 percent. The treatment method has short treatment time and high speed, is convenient to operate and is easy to realize. The micropore size distribution and the micropore surface charge reorganization of the treated active carbon adsorptive catalyst are well improved. The active carbon treated by the method is suitable for serving as the carrier of a synthesis catalyst for the industrial production of vinyl acetate.

Blends of amorphous and semicrystalline polymers having shape memory properties were prepared by blending a crystalline polymer such as poly(vinylidene fluoride), polylactide, poly(hydroxxybutyrate), poly(ethylene glycol) polyethylene, polyethylene-co-vinyl acetate, poly(vinyl chloride), poly(vinylidene chloride) and copolymers of poly(vinylidene chloride) and poly(vinyle chloride) and an amorphous polymer such as poly(vinyl acetate), poly methyl acrylate, poly ethyl acrylate, atactic poly methyl methacrylate, isotactic poly methyl methacrylate, syndiotactic poly methyl methacrylate and other poly alkyl methacrylates. The method for preparing the polymeric materials and applications thereof, for example, as smart medical devices, are also disclosed.

A coating composition in the form of a one or multi-part system, and method of applying such a composition under conditions of controlled humidity, for use in coating device surfaces to control and/or improve their ability to release bioactive agents in aqueous systems. The coating composition is particularly adapted for use with medical devices that undergo significant flexion and/or expansion in the course of their delivery and/or use, such as stents and catheters. The composition includes the bioactive agent in combination with a first polymer component such as polyalkyl(meth)acrylate, polyaryl(meth)acrylate, polyaralkyl(meth)acrylate, or polyaryloxyalkyl(meth)acrylate and a second polymer component such as poly(ethylene-co-vinyl acetate).

The present invention relates to a thermoplastic/natural cellulosic fiber composite, and more specifically to a high molecular weight compatibilizer within that composite resulting in both a high flex strength and high modulus and significant reduction in water absorption. The compatibilizer is preferably a terpolymer comprising: a) 0.5-20 percent by weight of monomer units selected from the group consisting of maleic anhydride, substituted maleic anhydride, mono-ester of maleic anhydride, itaconic anhydride, maleic acid, fumaric acid, crotonic acid, acrylic acid and methacrylic acid; b) 0 to 40 percent by weight of monomer units selected from styrene and functionalized styrene; and c) 40 to 98.5 percent by weight of monomer units selected from the group consisting of C_1-8 alkyl acrylates and methacrylates, and vinyl acetate.

The invention provides a high-elasticity sneaker air cushion sole and a production method thereof and researches a sneaker sole with high elasticity, high wear resistance and low hardness. The high-elasticity sneaker air cushion sole comprises a phylon (MD) midsole, an air cushion and a large sole which are sequentially and fixedly connected with one another from top to bottom, wherein an ethylene-vinyl acetate copolymer (EVA) cushion piece is assembled on a heel part of the air cushion; and the material formula of the MD midsole comprises the following components in parts by weight: 40-60 parts of EVA, 0-20 parts of ethylene propylene ternary gel, 0-30 parts of polyolefin elastomer (POE), 0-10 parts of talcum powder, 2.0-4.0 parts of a foaming agent, 0.6-1.0 part of a bridging agent, 1.0-2.0 part of a zinc oxide desulfurizing agent, 0.6-1.2 parts of stearic acid, 0.5-1.0 part of zinc stearate, 0.8-1.5 parts of a flow promotor and 0.3-0.8 part of a bridging addition agent.

The invention provides a bittern-free flame-proof thermal contraction sleeve which comprises (by weight ratio), (1) 100 parts of one or more selected from ethane-vinyl acetate copolymer (EVA), ethene-ethyl acrylate copolymer (EEA), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), (2) 5-50 parts of one or more selected from ethylene-propylene terpolymerisate rubber (EPDM), ethylene propylene rubber (EPM), dimethyl silicone rubber (MQ), methylvinyl silicone rubber (VMQ), methylsilicone rubber with phenyl and vinyl Group (PVMQ), thermoplastic elastomer styrene - butadiene - styrene blocked copolymer (SBS), styrene-isoprene blocked copolymer (SIS), (3) 50-100 parts of bittern-free flame retardant, and (4) 0.5-6 parts of coupling agent.